BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34010502)

  • 1. Als3-Th-cell-epitopes plus the novel combined adjuvants of CpG, MDP, and FIA synergistically enhanced the immune response of recombinant TRAP derived from Staphylococcus aureus in mice.
    Ma J; Liu W; Wang B; Yu S; Yu L; Song B; Yu Y; Zhu Z; Cui Y
    Immun Inflamm Dis; 2021 Sep; 9(3):971-983. PubMed ID: 34010502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The double adjuvants LTB and CpG significantly enhanced the immuno-protective effects of recombinant GIT derived from Staphylococcus aureus and Streptococcus in mice.
    Ma J; Yu L; Song B; Yu Y; Zhang S; Wei Y; Wu Z; Yao D; Yu W; Zhu Z; Cui Y
    J Med Microbiol; 2018 Mar; 67(3):432-440. PubMed ID: 29458538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel combinations of CTB, CpG, and aluminum hydroxide significantly enhanced the immunogenicity of clumping factor A
    Ma J; Wang B; Yu L; Song B; Yu Y; Wu S; Dong Y; Zhu Z; Cui Y
    Biosci Biotechnol Biochem; 2020 Sep; 84(9):1846-1855. PubMed ID: 32501144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved protective efficacy of a chimeric Staphylococcus aureus vaccine candidate iron-regulated surface determinant B ( N 126- P 361) -target of RNAIII activating protein in mice.
    Yu L; Wang N; Ma J; Tong C; Song B; Chi J; Ma G; Zhu Z; Cui Y
    Microbiol Immunol; 2013 Dec; 57(12):857-64. PubMed ID: 24117875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine.
    Yoo YC; Yoshimatsu K; Koike Y; Hatsuse R; Yamanishi K; Tanishita O; Arikawa J; Azuma I
    Vaccine; 1998; 16(2-3):216-24. PubMed ID: 9607033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund's complete adjuvant.
    Mitsuzawa E; Yasuda T; Tamura N; Ohtani S
    Jpn J Exp Med; 1984 Jun; 54(3):97-107. PubMed ID: 6084088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine Composition Formulated with a Novel
    Zhang H; Pan N; Ma C; Liu B; Xiu L; Tong H; Sheng S; Liang Y; Li H; Ma F; Bao X; Hu W; Wang X
    Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp160 of HIV-1.
    Levi M; Rudén U; Birx D; Loomis L; Redfield R; Lövgren K; Akerblom L; Sandström E; Wahren B
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):855-64. PubMed ID: 8315572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CD4+ T-cell epitopes on iron-regulated surface determinant B of Staphylococcus aureus.
    Yu S; Zhang H; Yao D; Liu W; Wang X; Chen X; Wei Y; Zhang Z; Wang J; Yu L; Sun H; Wu Z; Yu Y; Song B; Ma J; Tong C; Cui Y
    Microb Pathog; 2015 Dec; 89():108-13. PubMed ID: 26423555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
    Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL
    Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
    Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
    J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
    Tada H; Aiba S; Shibata K; Ohteki T; Takada H
    Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine.
    Koike Y; Yoo YC; Mitobe M; Oka T; Okuma K; Tono-oka S; Azuma I
    Vaccine; 1998 Dec; 16(20):1982-9. PubMed ID: 9796054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice.
    Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S
    Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of
    Chen Z; Gou Q; Xiong Q; Duan L; Yuan Y; Zhu J; Zou J; Chen L; Jing H; Zhang X; Luo P; Zeng H; Zou Q; Zhao Z; Zhang J
    Front Immunol; 2021; 12():684823. PubMed ID: 34122448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice.
    Ma J; Wang H; Zheng X; Xue X; Wang B; Wu H; Zhang K; Fan S; Wang T; Li N; Zhao Y; Gao Y; Yang S; Xia X
    Int Immunopharmacol; 2014 Mar; 19(1):74-80. PubMed ID: 24440303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice.
    Nazeri S; Zakeri S; Mehrizi AA; Djadid ND; Snounou G; Andolina C; Nosten F
    Med Microbiol Immunol; 2018 Nov; 207(5-6):271-286. PubMed ID: 29948091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses.
    Qiao M; Murata K; Davis AR; Jeong SH; Liang TJ
    Hepatology; 2003 Jan; 37(1):52-9. PubMed ID: 12500188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.